IOANNIS GIACHOS

Mr. IOANNIS GIACHOS


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in International Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
IGIOANNIS GIACHOS
IOANNIS GIACHOS
ATAnastasia Tsiogka
Anastasia Tsiogka
KMKonstantina Manoli
Konstantina Manoli
GTGeorge Tagaris
George Tagaris
TRTryfon Rotsos
Tryfon Rotsos
SDSpyridon Doumazos
Spyridon Doumazos
To evaluate the alterations of the retinal microvasculature and foveal avascular zone in patients with Parkinson's disease (PD) using optical coherence tomography angiography (OCT-A). A retrospective study of PD patients examined in the Ophthalmology Department of the General Hospital of Athens, “Georgios Gennimatas” from March 2021 to March 2022 was conducted. Totally 44 patients with PD were included and 18 healthy controls were examined, hence a total of 124 eyes were enrolled in the study. The foveal and parafoveal superficial and deep capillary plexus vascular density (fSCP-VD, fDCP-VD, pSCP-VD, pDCP-CD) and foveal avascular zone (FAZ) were quantified with OCTA. Optical coherence tomography (OCT) was used to measure macular thickness. Our statistical analysis was conducted by using a mixed effect linear regression model. After adjustment for age and gender, the mean parafoveal superficial capillary plexus vascular density (pSCP-VD) and mean parafoveal deep capillary plexus vascular density (pDCP-VD) were significantly decreased in individuals with PD (P<0.001 in both) by -2.35 (95%CI -3.3, -1.45) and -7.5 (95%CI -10.4, -4.6) respectively. fSCP-VD and fDCP-VD didn't approach statistical significance. The FAZ area and perimeter were significantly decreased (P<0.001 in both) by -0.1 mm2 (95%CI -0.13, -0.07) and -0.49 mm2 (95%CI -0.66, -0.32) respectively. Circularity didn't approach statistical significance. Central retinal thickness (CRT) was significantly decreased in individuals with PD (P<0.001) by -23.1 µm (95%CI -30.2, -16) and temporal retinal thickness (TRT) was decreased (P=0.025) by -11 µm (95%CI -22, -1.5) while nasal retinal thickness (NRT) only approached statistical significance (P=0.066). The mean pSCP-VD, pDCP-VD, CRT and TRT are significantly decreased and FAZ is altered in individuals with PD. These findings can be potentially used as biomarkers for the diagnosis and evaluation of early PD.

1 September 2021 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
IGIOANNIS GIACHOS
IOANNIS GIACHOS
ECEvangelia Chalkiadaki
Evangelia Chalkiadaki
KAKonstantinos Andreanos
Konstantinos Andreanos
CSChrysanthos Symeonidis
Chrysanthos Symeonidis
ACAlexandros Charonis
Alexandros Charonis
TRTryfon Rotsos
Tryfon Rotsos
To report a 71-year-old male patient diagnosed with epiretinal membrane-induced intraretinal neovascularization. The presence of an epiretinal membrane (ERM) was confirmed by Optical Coherence Tomography (OCT), fluorescein and indocyanine angiography. Optical coherence tomography angiography (OCT-A) revealed a neovascular membrane within the ERM. Intravitreal ranibizumab injections were administered three times at four-week intervals. Imaging revealed a stable membrane with no leakage. Five months after the third injection, OCT revealed intraretinal fluid. OCT-A showed a new branch of the neo-vascular membrane at the superficial capillary plexus. Following an additional ranibizumab injection, the membrane stabilized. It is conceivable that neovascularization developed due to, or in close conjunction with an epiretinal membranes already in place.

2 June 2021 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
KDKonstantinos Droutsas
Konstantinos Droutsas
PAPalaiologos Alexopoulos
Palaiologos Alexopoulos
IGIOANNIS GIACHOS
IOANNIS GIACHOS
EGEleftherios Giallouros
Eleftherios Giallouros
WSWalter Sekundo
Walter Sekundo
ALApostolos Lazaridis
Apostolos Lazaridis

Verified
Journal Article
Open access
PDF file
Michael TsatsosMichael Tsatsos
Michael Tsatsos
KKKonstantina Koulotsiou
Konstantina Koulotsiou
IGIOANNIS GIACHOS
IOANNIS GIACHOS
ITIoannis Tsinopoulos
Ioannis Tsinopoulos
NZNikolaos Ziakas
Nikolaos Ziakas
Purpose: Pellucid Marginal Degeneration (PMD) is a rare ectatic corneal disorder characterized by inferior peripheral thinning and significant irregular astigmatism. Despite its clinical similarities to keratoconus, PMD presents unique diagnostic and therapeutic challenges. This review aims to provide a comprehensive update on the pathophysiology, clinical features, diagnostic approaches, and management strategies for PMD, emphasizing the latest advancements in treatment options. Methods: A systematic literature search was performed in MEDLINE (via PubMed), Google Scholar, and Scopus up to February 2025 using the terms: “pellucid marginal degeneration,” “PMD,” “ectatic corneal disorders,” “keratoplasty in PMD,” “corneal cross-linking in PMD,” “ICRS in PMD,” “toric IOL PMD” and their Boolean combinations (AND/OR). The search was restricted to English-language studies involving human subjects, including case reports, case series, retrospective studies, clinical trials, and systematic reviews. A total of 76 studies met the inclusion criteria addressing treatment outcomes in PMD. Results: PMD is characterized by a crescent-shaped band of inferior corneal thinning, leading to high irregular astigmatism and reduced visual acuity. Diagnosis relies on advanced imaging techniques such as Scheimpflug-based corneal tomography, which reveals the characteristic “crab-claw” pattern. Conservative management includes rigid gas-permeable (RGP) lenses and scleral lenses, which provide effective visual rehabilitation in mild to moderate cases. Surgical options, such as CXL, ICRS, and toric IOLs, are reserved for advanced cases, with varying degrees of success. Newer techniques such as CAIRS, employing donor tissue instead of synthetic rings, show promising outcomes in corneal remodeling with potentially improved biocompatibility. Penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK) remain definitive treatments for severe PMD, though they are associated with significant risks, including graft rejection and postoperative astigmatism. Conclusions: PMD is a complex and progressive corneal disorder that requires a tailored approach to management. Early diagnosis and intervention are critical to optimizing visual outcomes. While conservative measures are effective in mild cases, surgical interventions offer promising results for advanced disease. Further research is needed to refine treatment protocols and improve long-term outcomes for patients with PMD.

18 September 2021 in Case Reports in Ophthalmological Medicine
Verified
Journal Article
Open access
PDF file
TRTryfon Rotsos
Tryfon Rotsos
IGIOANNIS GIACHOS
IOANNIS GIACHOS
KTKonstantinos Tyrlis
Konstantinos Tyrlis
CSChrysanthos Symeonidis
Chrysanthos Symeonidis
EMEkaterini Mani
Ekaterini Mani
IGIlias Georgalas
Ilias Georgalas
An unusual case of nitroglycerin-induced Paracentral Acute Middle Maculopathy (PAMM) is presented. A 50-year-old patient with sudden vision loss and scotoma was followed up with swept-source optical coherence tomography (SS-OCT), optical coherence tomography-angiography (OCT-A), and fluorescein angiography (FA). An anal fissure treated with glyceryl trinitrate (GTN) 0.2 ointment with headache and dizziness after application was reported. Fundoscopy OS revealed mild retinal venous dilatation and tortuosity with scattered blot hemorrhages and subtle, parafoveal, whitish lesions in the outer retina. SS-OCT revealed diffuse, hyperreflective lesions in the inner plexiform (IPL), inner nuclear (INL), and outer plexiform layers (OPL). OCT-A revealed focal dropout in the deep capillary plexus. FA showed masking due to blot hemorrhages and early punctuate leakage in the inner retina. This entity was identified as nitroglycerin-induced PAMM. Over the following 8 months, after discontinuation of the ointment application, the patient was symptom-free with stable visual acuity. OCT revealed INL/OPL thinning and confirmed complete lesion resolution. This first report of retinal vascular abnormalities due to nitrite ointment provides an insight into an unknown side effect of nitroglycerin ointment use. A dose-dependent correlation between GTN application and retinal vascular abnormalities remains to be confirmed.